Nuvalent Inc (NUVL)
86.88
-3.30
(-3.66%)
USD |
NASDAQ |
Nov 15, 16:00
86.84
-0.04
(-0.05%)
After-Hours: 20:00
Nuvalent 1 Year Total Returns (Daily): 47.25% for Nov. 15, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
November 15, 2024 | 47.25% |
November 14, 2024 | 53.34% |
November 13, 2024 | 58.77% |
November 12, 2024 | 60.05% |
November 11, 2024 | 66.03% |
November 08, 2024 | 65.14% |
November 07, 2024 | 65.10% |
November 06, 2024 | 67.75% |
November 05, 2024 | 63.11% |
November 04, 2024 | 58.88% |
November 01, 2024 | 66.21% |
October 31, 2024 | 69.88% |
October 30, 2024 | 78.73% |
October 29, 2024 | 78.41% |
October 28, 2024 | 81.89% |
October 25, 2024 | 71.81% |
October 24, 2024 | 80.47% |
October 23, 2024 | 86.41% |
October 22, 2024 | 100.8% |
October 21, 2024 | 98.13% |
October 18, 2024 | 95.44% |
October 17, 2024 | 92.17% |
October 16, 2024 | 80.83% |
October 15, 2024 | 76.62% |
October 14, 2024 | 78.12% |
Date | Value |
---|---|
October 11, 2024 | 69.26% |
October 10, 2024 | 66.66% |
October 09, 2024 | 62.27% |
October 08, 2024 | 58.71% |
October 07, 2024 | 60.21% |
October 04, 2024 | 82.46% |
October 03, 2024 | 144.0% |
October 02, 2024 | 126.1% |
October 01, 2024 | 124.1% |
September 30, 2024 | 122.5% |
September 27, 2024 | 117.2% |
September 26, 2024 | 140.1% |
September 25, 2024 | 136.1% |
September 24, 2024 | 132.4% |
September 23, 2024 | 134.1% |
September 20, 2024 | 153.4% |
September 19, 2024 | 134.4% |
September 18, 2024 | 130.7% |
September 17, 2024 | 121.2% |
September 16, 2024 | 136.8% |
September 13, 2024 | 85.51% |
September 12, 2024 | 73.86% |
September 11, 2024 | 78.02% |
September 10, 2024 | 84.03% |
September 09, 2024 | 87.72% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-60.51%
Minimum
Sep 06 2022
440.0%
Maximum
May 16 2023
115.7%
Average
97.73%
Median
1 Year Total Returns (Daily) Benchmarks
Viking Therapeutics Inc | 349.5% |
Bristol-Myers Squibb Co | 14.51% |
Replimune Group Inc | -3.23% |
Moderna Inc | -51.74% |
NovaBay Pharmaceuticals Inc | -94.01% |